Golden Green, Inc. G1 Therapeutics, Inc. Transaction History

Golden Green, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$4.04 - $8.51 $3,765 - $7,931	-932 Reduced 7.67%	11,220 $55,000
Q1 2022 Apr 18, 2022	SELL	$7.6 - $11.02 $222,892 - $323,194	-29,328 Reduced 70.7%	12,152 $92,000
Q4 2021 Jan 21, 2022	SELL	$10.16 - $16.17 $217,749 - $346,555	-21,432 Reduced 34.07%	41,480 $424,000
Q3 2021 Oct 08, 2021	BUY	$13.16 - $22.47 $40,769 - $69,612	3,098 Added 5.18%	62,912 $844,000
Q2 2021 Jul 14, 2021	BUY	$19.57 - $26.32 $34,247 - $46,060	1,750 Added 3.01%	59,814 $1.31 Million
Q1 2021 Apr 13, 2021	BUY	$17.58 - $32.59 $413,798 - $767,103	23,538 Added 68.17%	58,064 $1.4 Million
Q4 2020 Jan 25, 2021	BUY	$10.99 - $20.4 $379,440 - $704,330	34,526 New	34,526 $621,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

Stay updated on Golden Green, Inc. with notifications on news.